Rothschild Investment LLC’s Amneal Pharmaceuticals AMRX Stock Holding History

Rothschild Investment LLC’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$74.5K	Buy	4,301 +35	+0.8%	+$480	﹤0.01%	1143
2026 Q1	$53K	Sell	4,266 -5	-0.1%	-$67	﹤0.01%	1094
2025 Q4	$53.8K	Buy	4,271 +16	+0.4%	+$183	﹤0.01%	999
2025 Q3	$42.6K	Sell	4,255 -40	-0.9%	-$359	﹤0.01%	1036
2025 Q2	$34.7K	Buy	4,295 +45	+1%	+$339	﹤0.01%	877
2025 Q1	$35.6K	Buy	4,250 +60	+1%	+$501	﹤0.01%	863
2024 Q4	$33.2K	Buy	4,190 +15	+0.4%	+$126	﹤0.01%	878
2024 Q3	$34.7K	Buy	4,175 +115	+3%	+$899	﹤0.01%	867
2024 Q2	$25.8K	Buy	4,060 +40	+1%	+$254	﹤0.01%	913
2024 Q1	$24.4K	Buy	4,020 +20	+0.5%	+$113	﹤0.01%	882
2023 Q4	$24.3K	Buy	+4,000	New	+$17.8K	﹤0.01%	807

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFC

Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rothschild Investment LLC's AMRX Position: Q2 2026 in Review

Rothschild Investment LLC increased its Amneal Pharmaceuticals (AMRX) stake by 0.82% in Q2 2026, buying an estimated $480 and bringing the position to 4,301 shares worth $74.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Rothschild Investment LLC first reported a position in AMRX in Q4 2023 and has held it in 11 quarters since. 123 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Rothschild Investment LLC held 4,301 shares of Amneal Pharmaceuticals worth $74.5K as of Q2 2026.
Rothschild Investment LLC bought 35 Amneal Pharmaceuticals shares in Q2 2026, an estimated $480.
Amneal Pharmaceuticals made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #1143 holding.
Rothschild Investment LLC first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
123 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.